Cachexia in cancer patients.
Tisdale
Michael J
MJ
Pharmaceutical Sciences Research Institute, Aston University, Birmingham B4 7ET, UK. m.j.tisdale@aston.ac.uk
D000209:Acute-Phase Proteins / Q000378:metabolism; D000273:Adipose Tissue / Q000378:metabolism; D000818:Animals; D000855:Anorexia / Q000139:chemically induced / Q000209:etiology / Q000378:metabolism; D001823:Body Composition; D002100:Cachexia / Q000188:drug therapy / Q000209:etiology / Q000378:metabolism; D002352:Carrier Proteins / Q000502:physiology; D003546:Cysteine Endopeptidases / Q000378:metabolism; D016207:Cytokines / Q000502:physiology; D015118:Eicosapentaenoic Acid / Q000627:therapeutic use; D002149:Energy Intake; D004734:Energy Metabolism; D005395:Fish Oils / Q000627:therapeutic use; D006801:Humans; D007031:Hypothalamus / Q000503:physiopathology; D007473:Ion Channels; D008066:Lipolysis; D024101:Mitochondrial Proteins; D009097:Multienzyme Complexes / Q000378:metabolism; D009124:Muscle Proteins / Q000378:metabolism; D018482:Muscle, Skeletal / Q000378:metabolism; D009363:Neoplasm Proteins / Q000502:physiology; D009369:Neoplasms / Q000150:complications* / Q000378:metabolism; D009479:Neuropeptides / Q000502:physiology; D046988:Proteasome Endopeptidase Complex; D051381:Rats; D025801:Ubiquitin / Q000378:metabolism; D000071247:Uncoupling Protein 3; D015431:Weight Loss
D000209:Acute-Phase Proteins; D002352:Carrier Proteins; D016207:Cytokines; D005395:Fish Oils; D007473:Ion Channels; D024101:Mitochondrial Proteins; D009097:Multienzyme Complexes; D009124:Muscle Proteins; D009363:Neoplasm Proteins; D009479:Neuropeptides; D025801:Ubiquitin; D000071247:Uncoupling Protein 3; D015118:Eicosapentaenoic Acid; D003546:Cysteine Endopeptidases; D046988:Proteasome Endopeptidase Complex